Results 61 to 70 of about 46,789 (257)

The needle study: Machine learning as a new method for case‐finding in celiac disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite a well‐defined diagnostic work‐up, uncertainties persist regarding celiac disease (CeD) detection strategies in the general population. Machine learning (ML) algorithms offer promise in aiding medical decision‐making on clinical data.
Chiara Maria Trovato, Monica Montuori, Maria Ludovica Costanzo, Giusy Russo, Cosimo Ruggiero, Danila Volpe, Francesca Ferretti, Antonella Diamanti, Carlo Ciliberto, Salvatore Oliva   +9 more
wiley   +1 more source

MicroRNA-146a and Forkhead box protein 3 expressions in nonsegmental vitiligo: an insight into disease pathogenesis

Journal of the Egyptian Women’s Dermatologic Society, 2019
Background Autoimmune destruction of melanocytes is the principal hypothesis in vitiligo pathogenesis. MicroRNA-146a (miRNA-146a) is considered an essential regulator of posttranscriptional gene expression, suggesting a potential role in autoimmune ...
Arwa M Hassan, Yomna M. El-Hamd Neinaa, Amal S El-Bendary, Soha S Zakaria   +3 more
doaj   +1 more source

Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b Study

JEADV Clinical Practice, EarlyView.
This post hoc analysis examined the efficacy of ritlecitinib in subgroups of patients with vitiligo, defined by demographic and clinical characteristics. Patients completed the dose‐ranging and extension periods of the phase 2b study (NCT03715829) of ritlecitinib.
A. G. Pandya, I. Hamzavi, P. Ghosh, K. Ezzedine, J. E. Harris, R. Adiri, S. Chen, E. Peeva, Y. Yamaguchi   +8 more
wiley   +1 more source

Determination of elevated eosinophil to lymphocyte ratio, eosinophil to neutrophil ratio, eosinophil to monocyte ratio and its association with severe vitiligo: A retrospective cohort study.

PLoS ONE
BackgroundHematological markers such as eosinophil-to-lymphocyte (ELR), eosinophil-to-neutrophil (ENR), and eosinophil-to-monocyte (EMR) ratios may be used in the assessment of skin diseases.
Sarah Weissmann, Nitzan Burrack, Inbal Golan-Tripto, Amir Horev   +3 more
doaj   +1 more source

Vogt-Koyanagi-Harada Syndrome in a 10 Years Old Child [PDF]

, 2011
The Vogt-Koyanagi-Harada (VKH) syndrome is a rare systemic disorder of uveitis, dysacousia, vitiligo, premature graying of the hair, eyebrows and eyelashes, and meningoencephalitis. Although frequently unrecognised,VKH may affect children.
Singh, T, Sufi, AR, Zargar, S
core   +1 more source

Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of Vitiligo treatment success [PDF]

, 2015
Background: Patient-reported outcome measures are rarely used in vitiligo trials. The Vitiligo Noticeability Scale (VNS) is a new patient-reported outcome measure assessing how ‘noticeable’ the vitiligo patches are after treatment. The noticeability of
Bhandarkar, Conger, De Vet, Eleftheriadou, Eleftheriadou, Eleftheriadou, Ezzedine, Gonzalez, Gupta, Kang, Krishna, Lilly, Parsad, Terwee, Tour, Whitton   +15 more
core   +2 more sources

Public knowledge and attitude toward vitiligo in Saudi Arabia: A cross-sectional study

Journal of Dermatology and Dermatologic Surgery, 2021
Background: Knowledge and positive attitude toward vitiligo would foster support for affected individuals, improving their sense of well-being and possibly treatment outcome.
Malak A M Algarni, Waleed A Alqarni, Logain G Alghanemi, Maryam M Alnashri, Rand G Alghanemi, Nouf T Mleeh   +5 more
doaj   +1 more source

The Coexistence of Coeliac Disease, Psoriasis and Vitiligo [PDF]

, 2010
It has been defined that coeliac disease is associated with most of the autoimmune diseases including psoriasis and vitiligo. Here, a 26-year-old woman who was diagnosed palmoplantar pustular psoriasis and already had coeliac disease and vitiligo is ...
Ali Tahsin Güneş, Banu Lebe, Emel Fetil, Gökşen Yücel, Sevgi Akarsu, Turna İlknur   +5 more
core   +2 more sources

Vitiligo - Part 1 [PDF]

Anais Brasileiros de Dermatologia, 2014
Vitiligo is a chronic stigmatizing disease, already known for millennia, which mainly affects melanocytes from epidermis basal layer, leading to the development of hypochromic and achromic patches. Its estimated prevalence is 0.5% worldwide. The involvement of genetic factors controlling susceptibility to vitiligo has been studied over the last decades,
Tarlé, Roberto Gomes, Nascimento, Liliane Machado do, Mira, Marcelo Távora, Castro, Caio Cesar Silva de   +3 more
openaire   +5 more sources

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

JEADV Clinical Practice, EarlyView.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson, Kara Hurley, Hannah Chaudhury, Lara Shehadeh, Cameron West   +4 more
wiley   +1 more source